A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 25,285 shares of ARCT stock, worth $417,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,285
Previous 27,256 7.23%
Holding current value
$417,961
Previous $663,000 11.61%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $35,635 - $50,023
-1,971 Reduced 7.23%
25,285 $586,000
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $401,921 - $732,701
-16,506 Reduced 37.72%
27,256 $663,000
Q1 2024

May 14, 2024

SELL
$31.23 - $42.99 $108,368 - $149,175
-3,470 Reduced 7.35%
43,762 $1.48 Million
Q4 2023

May 16, 2024

BUY
$17.71 - $32.97 $61,453 - $114,405
3,470 Added 7.93%
47,232 $1.49 Million
Q4 2023

Feb 02, 2024

SELL
$17.71 - $32.97 $195,305 - $363,593
-11,028 Reduced 18.93%
47,232 $1.49 Million
Q3 2023

Nov 13, 2023

SELL
$25.44 - $37.35 $39,915 - $58,602
-1,569 Reduced 2.62%
58,260 $1.49 Million
Q2 2023

Jul 24, 2023

BUY
$23.94 - $32.36 $1.43 Million - $1.94 Million
59,829 New
59,829 $1.72 Million
Q1 2023

May 11, 2023

BUY
$14.72 - $23.97 $55,141 - $89,791
3,746 Added 5.65%
70,070 $1.68 Million
Q4 2022

Jan 24, 2023

BUY
$14.14 - $23.06 $94,836 - $154,663
6,707 Added 11.25%
66,324 $1.13 Million
Q3 2022

Nov 04, 2022

SELL
$13.05 - $22.13 $851,134 - $1.44 Million
-65,221 Reduced 52.24%
59,617 $884,000
Q2 2022

Jul 22, 2022

SELL
$12.26 - $31.17 $1.13 Million - $2.88 Million
-92,425 Reduced 42.54%
124,838 $1.97 Million
Q1 2022

May 09, 2022

SELL
$17.64 - $39.57 $862,719 - $1.94 Million
-48,907 Reduced 18.37%
217,263 $5.86 Million
Q4 2021

Feb 15, 2022

SELL
$34.2 - $47.56 $14.2 Million - $19.7 Million
-414,079 Reduced 60.87%
266,170 $9.85 Million
Q3 2021

Nov 12, 2021

SELL
$27.88 - $58.25 $628,108 - $1.31 Million
-22,529 Reduced 3.21%
680,249 $32.5 Million
Q2 2021

Jul 23, 2021

BUY
$25.79 - $42.11 $7.41 Million - $12.1 Million
287,237 Added 69.12%
702,778 $23.8 Million
Q1 2021

May 10, 2021

BUY
$38.75 - $86.92 $3.08 Million - $6.91 Million
79,464 Added 23.64%
415,541 $17.2 Million
Q4 2020

Feb 24, 2021

SELL
$34.61 - $123.66 $6.83 Million - $24.4 Million
-197,254 Reduced 36.99%
336,077 $14.6 Million
Q4 2020

Feb 12, 2021

BUY
$34.61 - $123.66 $13.8 Million - $49.2 Million
398,063 Added 294.28%
533,331 $14.6 Million
Q3 2020

Nov 10, 2020

BUY
$37.49 - $63.19 $5.07 Million - $8.55 Million
135,268 New
135,268 $5.9 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.